RecruitingNot ApplicableNCT02097758

Efficacy of Three Dimensional Transesophageal Echocardiography for Percutaneous Device Closure in Atrial Septal Defect


Sponsor

Asan Medical Center

Enrollment

100 participants

Start Date

Mar 1, 2014

Study Type

INTERVENTIONAL

Conditions

Summary

Background: Three-dimensional echocardiographic image for atrial septal defect (ASD) is useful for evaluation of defect size and shape. The investigators suggested optimal device size using three-dimensional transesophageal echocardiographic image and our formula in previous study. Purpose: In this study, the investigators seek to predict the correct device size and confirm the accuracy of the formula that we made before device closure in ASD patients.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Inclusion Criteria3

  • Age ≥18 year-old
  • Susceptible indication for atrial septal defect closure
  • Potential candidate for device closure

Exclusion Criteria2

  • Poor candidate for device closure: multiple ASDs, ect
  • Other heart disease requiring open heart surgery

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICETranscatheter device closure

Closure of atrial septal defect with device * choosing device size with 3D image and the formula * we do not use sizing balloon for choosing of the device size


Locations(1)

Asan Medical Center

Seoul, South Korea

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02097758


Related Trials